Clinical Trials Logo

Severe Bleeding clinical trials

View clinical trials related to Severe Bleeding.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03537521 Withdrawn - Urgent Surgery Clinical Trials

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

Start date: April 2020
Phase:
Study type: Observational [Patient Registry]

Patients treated with Vitamin K antagonists (VKA) or direct oral anticoagulants as Rivaroxaban, Apixaban, Edoxaban or Dabigatran, who experience severe bleeding and/or need urgent interventions/operations that cannot wait are included in this registry, or during emergency operations